Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

 
Neuigkeiten 24. Dezember 2025 bis 1. Januar 2026: Die Deutsche Nationalbibliothek bleibt an beiden Standorten geschlossen. // 24 December 2025 to 1 January 2026: The German National Library will be closed at both locations.
 
 
 


Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

11 - 20 von 8428
<< < > >>


Artikel 11 Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials
Enthalten in Dermatology Bd. 241, 2025, Nr. 4: 325-335. 11 S.
Online Ressource
Artikel 12 Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials
Enthalten in Dermatology Bd. 241, 2025, Nr. 3: 272-286. 15 S.
Online Ressource
Artikel 13 Time to Loss of Disease Control following Guselkumab Withdrawal in Relation to Initial Speed of Response: A post hoc Analysis of the VOYAGE 2 Trial
Enthalten in Dermatology Bd. 241, 2025, Nr. 2: 133-142. 10 S.
Online Ressource
Artikel 14 Predicting Cow’s Milk Challenge Outcomes in Children: Multivariate Analysis of Clinical Predictors
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 11: 1022-1032. 11 S.
Online Ressource
Artikel 15 Upadacitinib and Dupilumab Demonstrate Superior Efficacy in the Treatment of Adolescent Atopic Dermatitis: A Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 9: 896-906. 11 S.
Online Ressource
Artikel 16 Efficacy and Safety of Specific Immunotherapy Combined with Biologics in Allergic Rhinitis and Asthma: A Systematic Review and Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 9: 851-869. 19 S.
Online Ressource
Artikel 17 Efficacy and Safety of Tumor Necrosis Factor Inhibitors, Interleukin-17 Inhibitors, and Janus Kinase Inhibitors in Patients with Non-Radiographic Axial Spondyloarthritis: A Systematic Review and Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 8: 784-801. 18 S.
Online Ressource
Artikel 18 Advanced Biologic Therapies in the Management of Asthma in Children and Adolescents: A Comprehensive Network Meta-Analysis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 8: 733-746. 14 S.
Online Ressource
Artikel 19 Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 7: 670-677. 8 S.
Online Ressource
Artikel 20 Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis
Enthalten in International archives of allergy and immunology Bd. 186, 2025, Nr. 7: 670-677. 8 S.
Online Ressource


11 - 20 von 8428
<< < > >>


E-Mail-IconAdministration